Health TrialsbyHealthPanel

Preliminary Effectiveness of Enhanced Text Message + Incentives

ConditionsSmoking CessationPregnancy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Kansas Medical Center

About this trial

This study is a preliminary evaluation of a smoking cessation intervention designed for pregnant women that combines text message support and financial incentives.

The aims of this study are to determine the preliminary feasibility and acceptability of text message + incentives (intervention) vs. text message only (control).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnant women aged: 18+

Enrolled in the Special Supplemental Nutrition Program for women, Infants, and Children (WIC) or Medicaid (or applied/applying)

Self-reported current daily smokers

Able to communicate in English

Disqualifiers

Not at all interested in quitting

Smoke less than 24 days in the past month

Greater than 30 weeks gestation

Trial design

Design model

Parallel

Treatments tested in this trial

  • Text Messages

    Behavioral

    Intervention Component - Text messages (SmokeFreeTXT library with pregnancy related messages) participants will receive scheduled messages to support quitting and prevent relapse.

  • Incentives

    Behavioral

    Incentives for abstinence - Weeks 1-4; 8; 12: Twice daily CO assessments with verification sent via text-message. Participants will receive daily incentives ranging each day of smoking abstinence.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Text Messaging + IncentivesExperimental treatment 2 interventions
Group B: Text Messaging OnlyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility of Intervention

Retention rate.

Time frame
12 weeks post-randomization
2

Smoking Abstinence

Biochemically verified smoking abstinence (exhaled CO)

Time frame
12 weeks post-randomization
3

Acceptability of Intervention

Participant ratings of acceptability.

Time frame
12 weeks post-randomization

Secondary outcomes

1

Smoking Abstinence

Exhaled CO

Time frame
26 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Kansas Medical Center

Lead sponsor

National Institute of General Medical Sciences (NIGMS)

Collaborator

Source ClinicalTrials.gov
Apply now